I too am looking forward to Monday. Clearly Peregrine has the potential to be a very lucrative buyout for us. I will not be confident that it will happen until we get more news - undisputed doubling of MOS over the SOC in any major cancer will probably do the trick. Doubling it in more than one will justify the unbridled enthusiasm seen here today. We don't have the definitive doubling data yet, curse those 3rd party contractor idiots. I would suggest keeping your day jobs for a little while longer.
News 
Market Data 
Discover 
